Daiichi Sankyo reports positive results from Phase I/II U3-1402 trial
Daiichi Sankyo has reported new positive efficacy and safety results from its ongoing Phase I/II...
Daiichi Sankyo has reported new positive efficacy and safety results from its ongoing Phase I/II...